US Broker Ratings

TotalEnergies SE (TTE) Stock Analysis: Exploring a 11.12% Potential Upside in the Energy Sector

TotalEnergies SE (NYSE: TTE) stands as a formidable player in the integrated oil and gas industry, with a market capitalization of $134.62 billion. Based in France, this multi-energy company has..

Asana, Inc. (ASAN) Investor Outlook: Analyzing a Potential 18% Upside

Asana, Inc. (NYSE: ASAN), a prominent player in the Technology sector’s Software – Application industry, presents a compelling case for investors seeking growth opportunities in the fast-evolving work management software..

Phathom Pharmaceuticals, Inc. (PHAT) Stock Analysis: Exploring a 57.98% Potential Upside

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) has emerged as a notable player within the biotechnology sector, focusing on innovative treatments for gastrointestinal diseases. Headquartered in Florham Park, New Jersey, this biopharmaceutical..

Yalla Group Limited (YALA) Stock Analysis: Exploring a 26.77% Potential Upside with Robust Revenue Growth

Investors focusing on the dynamic intersection of social networking and gaming should keep a keen eye on Yalla Group Limited (NYSE: YALA). Headquartered in Dubai, this tech company is carving..

Fulcrum Therapeutics, Inc. (FULC) Investor Outlook: Navigating a 38.68% Potential Upside in the Biotech Sector

Fulcrum Therapeutics, Inc. (NASDAQ: FULC), a clinical-stage biopharmaceutical company, is drawing attention in the biotechnology sector with its innovative approach to targeting genetically defined diseases. Headquartered in Cambridge, Massachusetts, Fulcrum..

Palvella Therapeutics, Inc. (PVLA) Investor Outlook: Exploring a Biotech Stock with a Promising 8% Upside

Palvella Therapeutics, Inc. (NASDAQ: PVLA) has captured the attention of investors in the biotech sector, thanks to its innovative approach to treating rare genetic skin diseases. With a current market..

Asure Software (ASUR) Stock Analysis: Exploring a 64% Potential Upside for Tech-Savvy Investors

Investors with an eye on the technology sector might find Asure Software Inc (NASDAQ: ASUR) an intriguing option, given its substantial potential upside of 64.48%, as indicated by analyst target..

Compass Therapeutics, Inc. (CMPX) Stock Analysis: Unveiling a Potential 241% Upside in the Biotech Sector

Compass Therapeutics, Inc. (NASDAQ: CMPX) is making waves in the biotechnology industry with its promising pipeline of antibody-based therapeutics aimed at tackling various human diseases, particularly cancer. Headquartered in Boston,..

Alpha Tau Medical Ltd. (DRTS) Stock Analysis: Biotechnology Innovator with Over 107% Upside Potential

Alpha Tau Medical Ltd. (NASDAQ: DRTS) emerges as a compelling opportunity for investors with a keen interest in the biotechnology sector, particularly those focused on innovative cancer treatments. This Israel-based..

Candel Therapeutics, Inc. (CADL): Investor Outlook and 239% Potential Upside Sparks Interest

Candel Therapeutics, Inc. (CADL), a promising player in the biotechnology sector, is capturing investor attention with a potential upside of 239.25%. This clinical-stage biopharmaceutical company, headquartered in Needham, Massachusetts, specializes..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: Exploring a 20% Upside Potential for Investors in the Healthcare Sector

ClearPoint Neuro Inc. (NASDAQ: CLPT) is making waves in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $685.39 million, ClearPoint is a noteworthy contender..

Viemed Healthcare, Inc. (VMD) Stock Analysis: A Look at Its Impressive 98.78% Potential Upside

Investors with an eye on the healthcare sector might find Viemed Healthcare, Inc. (NASDAQ: VMD) an intriguing addition to their portfolios. With a market capitalization of $253.66 million, Viemed stands..

Cartesian Therapeutics, Inc. (RNAC) Stock Analysis: Eyeing a 344% Potential Upside

Cartesian Therapeutics, Inc. (RNAC), a clinical-stage biotechnology firm specializing in mRNA cell therapies for autoimmune diseases, has captured investor attention with an impressive potential upside of 344.25%. Despite the current..

Nyxoah SA (NYXH) Stock Analysis: Exploring a 149% Potential Upside in Medical Tech Innovation

Nyxoah SA (NASDAQ: NYXH), a Belgian medical technology firm, is captivating investor attention with its innovative approach to treating obstructive sleep apnea (OSA). With a market capitalization of $193.2 million,..

Neuronetics, Inc. (STIM) Stock Analysis: Exploring a 124% Potential Upside in the Healthcare Sector

Neuronetics, Inc. (NASDAQ: STIM) is an intriguing player in the healthcare sector, specifically within the medical devices industry. Headquartered in Malvern, Pennsylvania, this innovative company is at the forefront of..

UroGen Pharma Ltd. (URGN) Stock Analysis: Assessing a 70% Potential Upside for Investors

UroGen Pharma Ltd. (URGN), a Princeton-based biotechnology company, is attracting significant attention from investors due to its innovative approach to treating urothelial and specialty cancers. With a market capitalization of..

Heron Therapeutics, Inc. (HRTX) Stock Analysis: Unpacking a 305.98% Potential Upside in Biotech

Heron Therapeutics, Inc. (NASDAQ: HRTX), a commercial-stage biotechnology firm, has captured the attention of investors with a staggering potential upside of 305.98%. Let’s delve into what makes this company a..

Varex Imaging Corporation (VREX) Stock Report: Navigating a 48% Potential Upside Despite Current Challenges

Varex Imaging Corporation (NASDAQ: VREX), a significant player in the healthcare sector specializing in medical devices, presents an intriguing prospect for investors keen on navigating the complexities of the X-ray..

XOMA Royalty Corporation (XOMA): Investor Outlook with 108.93% Upside Potential

XOMA Royalty Corporation (NASDAQ: XOMA) is gaining attention in the biotechnology sector with its unique business model and significant growth potential. Headquartered in Emeryville, California, XOMA operates as a biotech..

Chevron Corporation (CVX) Stock Analysis: Navigating the Energy Giant with a 9.65% Potential Upside

Investors with a keen eye on the energy sector often find themselves drawn to Chevron Corporation (NYSE: CVX), a stalwart in the oil and gas integrated industry. With a market..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds